Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

May 01, 2019; Volume 16,Issue 2

Editorial

  • You have access
    Immunosuppressive checkpoint Siglec-15: a vital new piece of the cancer immunotherapy jigsaw puzzle
    Xiubao Ren
    Cancer Biology & Medicine May 2019, 16 (2) 205-210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0141

Review

  • You have access
    The functional role of miRNAs in colorectal cancer: insights from a large population-based study
    Lila E. Mullany and Martha L. Slattery
    Cancer Biology & Medicine May 2019, 16 (2) 211-219; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0514

Original Article

  • You have access
    Dorsomorphin induces cancer cell apoptosis and sensitizes cancer cells to HSP90 and proteasome inhibitors by reducing nuclear heat shock factor 1 levels
    Na Li, Ting Wang, Zongmeng Li, Xiaoli Ye, Bo Deng, Shu Zhuo, Pengle Yao, Mengmei Yang, Hong Mei, Xiaofang Chen, Tengfei Zhu, Shiting Chen, Hui Wang, Jiming Wang and Yingying Le
    Cancer Biology & Medicine May 2019, 16 (2) 220-235; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0235
  • You have access
    Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer
    Rebecca Carter, Azadeh Cheraghchi-Bashi, Adam Westhorpe, Sheng Yu, Yasmin Shanneik, Elena Seraia, Djamila Ouaret, Yasuhiro Inoue, Catherine Koch, Jenny Wilding, Daniel Ebner, Anderson J. Ryan, Francesca M. Buffa and Ricky A. Sharma
    Cancer Biology & Medicine May 2019, 16 (2) 234-246; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0284
  • You have access
    Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics
    Jelena Grahovac, Tatjana Srdić-Rajić, Juan Francisco Santibañez, Marijana Pavlović, Milena Čavić and Siniša Radulović
    Cancer Biology & Medicine May 2019, 16 (2) 247-263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0375
  • You have access
    Effects of palbociclib on oral squamous cell carcinoma and the role of PIK3CA in conferring resistance
    Nur Syafinaz Zainal, Bernard Kok Bang Lee, Zheng Wei Wong, Iuan Sheau Chin, Pei San Yee, Chai Phei Gan, Kein Seong Mun, Zainal Ariff Abdul Rahman, J. Silvio Gutkind, Vyomesh Patel and Sok Ching Cheong
    Cancer Biology & Medicine May 2019, 16 (2) 264-275; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0257
  • You have access
    Hepatitis B virus X protein enhances hepatocarcinogenesis by depressing the targeting of NUSAP1 mRNA by miR-18b
    Zhe Yang, Jiong Li, Guoxing Feng, Yuan Wang, Guang Yang, Yunxia Liu, Shuqin Zhang, Jinyan Feng and Xiaodong Zhang
    Cancer Biology & Medicine May 2019, 16 (2) 276-287; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0283
  • You have access
    Attenuated plasmodium sporozoite expressing MAGE-A3 induces antigen-specific CD8+ T cell response against lung cancer in mice
    Dong Zhou, Hong Zheng, Quanxing Liu, Xiao Lu, Xufeng Deng, Li Jiang, Bing Hou, Yong Fu, Feng Zhu, Yan Ding, Wenyue Xu and Jigang Dai
    Cancer Biology & Medicine May 2019, 16 (2) 288-298; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0309
  • You have access
    Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer
    Huizhi Sun, Nan Yao, Siqi Cheng, Linqi Li, Shiqi Liu, Zhao Yang, Guanjie Shang, Danfang Zhang and Zhi Yao
    Cancer Biology & Medicine May 2019, 16 (2) 299-311; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0209
  • You have access
    Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
    Jing Si, Benlong Yang, Rong Guo, Naisi Huang, Chenlian Quan, Linxiaoxi Ma, Bingqiu Xiu, Yun Cao, Yue Tang, Linxiao Shen, Jiajian Chen and Jiong Wu
    Cancer Biology & Medicine May 2019, 16 (2) 312-318; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0159
  • You have access
    Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
    Andreas M. Luebke, Ali Attarchi-Tehrani, Jan Meiners, Claudia Hube-Magg, Dagmar S. Lang, Martina Kluth, Maria Christina Tsourlakis, Sarah Minner, Ronald Simon, Guido Sauter, Franziska Büscheck, Frank Jacobsen, Andrea Hinsch, Stefan Steurer, Thorsten Schlomm, Hartwig Huland, Markus Graefen, Alexander Haese, Hans Heinzer, Till S. Clauditz, Eike Burandt, Waldemar Wilczak and Doris Höflmayer
    Cancer Biology & Medicine May 2019, 16 (2) 319-330; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0384
  • You have access
    LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival
    Yi Que, Zhixin Fang, Yuanxiang Guan, Wei Xiao, Bushu Xu, Jingjing Zhao, Huoying Chen, Xinke Zhang, Musheng Zeng, Yao Liang and Xing Zhang
    Cancer Biology & Medicine May 2019, 16 (2) 331-340; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0306
  • You have access
    Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial data
    Ashley M. Hopkins, Adel Shahnam, Sasha Zhang, Chris S. Karapetis, Andrew Rowland and Michael J. Sorich
    Cancer Biology & Medicine May 2019, 16 (2) 341-349; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0474
  • You have access
    Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients
    Yuhan Zhang, Shuaibing Wang, Beibei Yang, Su Lu, Yiyi Du and Hong Liu
    Cancer Biology & Medicine May 2019, 16 (2) 350-360; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0378
  • You have access
    Genetic polymorphisms and gastric cancer risk: a comprehensive review synopsis from meta-analysis and genome-wide association studies
    Jie Tian, Guanchu Liu, Chunjian Zuo, Caiyang Liu, Wanlun He and Huanwen Chen
    Cancer Biology & Medicine May 2019, 16 (2) 361-389; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0290
  • You have access
    Cytosolic phospholipase A2α modulates cell-matrix adhesion via the FAK/paxillin pathway in hepatocellular carcinoma
    Piao Guo, Yuchao He, Lu Chen, Lisha Qi, Dongming Liu, Ziye Chen, Manyu Xiao, Liwei Chen, Yi Luo, Ning Zhang and Hua Guo
    Cancer Biology & Medicine May 2019, 16 (2) 377-390; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0386
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 16 (2)
Cancer Biology & Medicine
Vol. 16, Issue 2
1 May 2019
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorial
  • Review
  • Original Article

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire